AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Spire Healthcare Group PLC

Remuneration Information Jun 2, 2015

5328_dirs_2015-06-02_c6e42b78-ba69-4d5d-a2ec-3d6e0d0ca5a9.html

Remuneration Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9166O

Spire Healthcare Group PLC

02 June 2015

Spire Healthcare Group Plc

2 June 2015

Notification of Transactions of Persons Discharging Managerial Responsibilities

This notification is made in accordance with DTR 3.1.4R (1) (a) of the Disclosure Rules and Transparency Rules.

Grant of Deferred Share Bonus Plan Awards

Spire Healthcare Group plc (the Company) announces that on 1 June 2015, awards (the Awards) were granted over the Company's ordinary shares in the form of nil-cost options to the Directors named below, under the Spire Healthcare Group plc Deferred Share Bonus Plan (the "DBP"). 

Under the DBP, Executive Directors are required to defer a proportion of their gross cash bonus into shares in the Company for a period of three years. The Directors listed below have the following interest in shares as deferred share bonus awards under the DBP, with each amount equivalent to 33% of their 2014 gross cash bonus as disclosed in the 2014 Annual Report and Accounts:

Name                      Director/PDMR          Deferred Shares 

Rob Roger                     Director                             18,057        

Simon Gordon               Director                             10,922        

The share price used to determine the number of Deferred Shares subject to award was 360.60p, the mid-market closing share price at close of business over the dealing day on 29 May 2015.

The awards will vest on the third anniversary of the grant date on 1 June 2018, subject to continued employment.  Upon vesting, the options will remain exercisable until 1 June 2025.

Name of contact and telephone number for queries:

A M Dand                                         

Interim Deputy Company Secretary

Spire Healthcare Group plc

Tel:      020 7427 9092

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSGIGDLLSGBGUD

Talk to a Data Expert

Have a question? We'll get back to you promptly.